Rapid review of Systematic reviews on the efficacy and safety of Vitamin C in the management of Acute Respiratory Infection and Disease Authors
Field | Value | Language |
dc.contributor.author | Schloss, Janet | en_AU |
dc.contributor.author | Lauche, Romy | en_AU |
dc.contributor.author | Harnett, Joanne | en_AU |
dc.contributor.author | Hannan, Nicole | en_AU |
dc.contributor.author | Brown, Danielle | en_AU |
dc.contributor.author | Greenfield, Tom | en_AU |
dc.contributor.author | Steel, Amie | en_AU |
dc.date.accessioned | 2020-08-14 | |
dc.date.available | 2020-08-14 | |
dc.date.issued | 2020 | en_AU |
dc.identifier.uri | https://hdl.handle.net/2123/23080 | |
dc.description.abstract | Current evidence from published systematic reviews indicate that oral intake of vitamin C may assist with symptoms of acute viral respiratory infections (ARI) by reducing fever and chills, relieving chest pain and assist in reducing symptoms of common cold-induced asthma. Intravenous (IV) vitamin C administration may reduce the need for vasopressor support and the duration of mechanical ventilations in critically ill patients in hospital. COVID-19 has similar signs and symptoms of ARI. Further studies involving patients with COVID-19, either through administration of oral vitamin C in mild cases or IV vitamin C in critical cases, would be advantageous to examine if it is safe and efficacious. | en_AU |
dc.language.iso | en | en_AU |
dc.subject | COVID-19 | en_AU |
dc.subject | Coronavirus | en_AU |
dc.title | Rapid review of Systematic reviews on the efficacy and safety of Vitamin C in the management of Acute Respiratory Infection and Disease Authors | en_AU |
dc.type | Article | en_AU |
dc.identifier.doi | 10.1016/j.aimed.2020.07.008 |
Associated file/s
There are no files associated with this item.
Associated collections